• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

薯蓣皂苷能下调 MDR1 从而增加体内外甲氨蝶呤的吸收。

Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo.

机构信息

Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, Liaoning, PR China.

Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, Liaoning, PR China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian, Liaoning, PR China.

出版信息

Toxicol Appl Pharmacol. 2014 Jun 1;277(2):146-54. doi: 10.1016/j.taap.2014.03.013. Epub 2014 Mar 26.

DOI:10.1016/j.taap.2014.03.013
PMID:24680847
Abstract

The purpose of this study was to investigate the enhancing effect of dioscin on the absorption of methotrexate (MTX) and clarify the molecular mechanism involved in vivo and in vitro. Dioscin increased MTX chemosensitivity and transepithelial flux in the absorptive direction, significantly inhibiting multidrug resistance 1 (MDR1) mRNA and protein expression and MDR1 promoter and nuclear factor κ-B (NF-κB) activities in Caco-2 cells. Moreover, inhibitor κB-α (IκB-α) degradation was inhibited by dioscin. Dioscin enhanced the intracellular concentration of MTX by down-regulating MDR1 expression through a mechanism that involves NF-κB signaling pathway inhibition in Caco-2 cells. Dioscin strengthened MTX absorption by inhibiting MDR1 expression in rat intestine. In addition, even though MTX is absorbed into the enterocytes, there was no increase in toxicity observed, and that, in fact, decreased toxicity was seen.

摘要

本研究旨在探讨薯蓣皂苷元对甲氨蝶呤(MTX)吸收的增强作用,并阐明其体内和体外涉及的分子机制。薯蓣皂苷元可增加 MTX 的化疗敏感性和吸收方向的跨上皮通量,显著抑制 Caco-2 细胞中多药耐药基因 1(MDR1)mRNA 和蛋白表达,以及 MDR1 启动子和核因子 κ-B(NF-κB)活性。此外,薯蓣皂苷元还可抑制抑制剂 κB-α(IκB-α)降解。薯蓣皂苷元通过抑制 Caco-2 细胞中 NF-κB 信号通路,下调 MDR1 表达,从而增强 MTX 的细胞内浓度。薯蓣皂苷元在大鼠肠道中通过抑制 MDR1 表达来增强 MTX 的吸收。此外,即使 MTX 被肠细胞吸收,也没有观察到毒性增加,反而观察到毒性降低。

相似文献

1
Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo.薯蓣皂苷能下调 MDR1 从而增加体内外甲氨蝶呤的吸收。
Toxicol Appl Pharmacol. 2014 Jun 1;277(2):146-54. doi: 10.1016/j.taap.2014.03.013. Epub 2014 Mar 26.
2
Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.薯蓣皂苷元通过抑制 NF-κB 信号通路下调 MDR1 恢复多药耐药人白血病 K562/阿霉素细胞中抗癌药物阿霉素的活性。
J Nat Prod. 2013 May 24;76(5):909-14. doi: 10.1021/np400071c. Epub 2013 Apr 26.
3
Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1.薯蓣皂苷通过诱导自噬增强阿霉素在 MCF-7 和 MCF-7/ADR 细胞中的疗效:不仅仅是下调多药耐药蛋白 1。
Sci Rep. 2016 Jun 22;6:28403. doi: 10.1038/srep28403.
4
Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.葛根素通过 NF-κB 通路抑制乳腺癌 MCF-7/adr 细胞多药耐药基因 1 的分子机制及其对细胞 AMP 激活蛋白激酶转录活性的影响
Mol Nutr Food Res. 2010 Jul;54(7):918-28. doi: 10.1002/mnfr.200900146.
5
Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.谷氨酰胺和精氨酸可改善甲氨蝶呤处理的 Caco-2 细胞的通透性和紧密连接蛋白表达。
Clin Nutr. 2013 Oct;32(5):863-9. doi: 10.1016/j.clnu.2013.01.014. Epub 2013 Feb 1.
6
Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.薯蓣皂苷元对人肝癌 HepG2/阿霉素多药耐药细胞的逆转作用。
Eur J Pharmacol. 2011 Mar 5;654(2):129-34. doi: 10.1016/j.ejphar.2010.12.018. Epub 2010 Dec 31.
7
The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.蛋白酶体抑制剂硼替佐米通过核因子κB途径逆转P-糖蛋白介导的白血病多药耐药。
Pharmazie. 2012 Feb;67(2):187-92.
8
Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.甲氨蝶呤-苯丁抑制素相互作用:在大鼠体内涉及 P-糖蛋白和有机阴离子转运体。
Int J Pharm. 2014 Apr 25;465(1-2):368-77. doi: 10.1016/j.ijpharm.2014.02.020. Epub 2014 Feb 13.
9
PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.PSC833,环孢素类似物,通过激活 JNK/c-Jun/AP-1 并抑制 NF-κB 下调 MDR1 表达。
Cancer Chemother Pharmacol. 2010 May;65(6):1131-6. doi: 10.1007/s00280-009-1121-7. Epub 2009 Sep 18.
10
Dioscin attenuates gastric ischemia/reperfusion injury through the down-regulation of PKC/ERK1/2 signaling via PKCα and PKCβ2 inhibition.薯蓣皂苷元通过抑制蛋白激酶 Cα和蛋白激酶 Cβ2下调蛋白激酶 C/细胞外信号调节激酶 1/2 信号通路减轻胃缺血再灌注损伤。
Chem Biol Interact. 2016 Oct 25;258:234-44. doi: 10.1016/j.cbi.2016.09.014. Epub 2016 Sep 17.

引用本文的文献

1
The effects of polysaccharides, tragacanthin, and bassorin on .多糖、黄芪胶和黄蓍胶对……的影响
Res Pharm Sci. 2023 Jun 1;18(4):381-391. doi: 10.4103/1735-5362.378085. eCollection 2023 Jul-Aug.
2
Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer via Promoting c-myc Ubiquitination and Subsequent Hexokinase-2 Suppression.薯蓣皂苷通过促进c-myc泛素化及随后的己糖激酶-2抑制,抑制结直肠癌中的糖酵解并诱导细胞凋亡。
Onco Targets Ther. 2020 Jan 6;13:31-44. doi: 10.2147/OTT.S224062. eCollection 2020.
3
Recent Advances in the Pharmacological Activities of Dioscin.
薯蓣皂苷的药理活性研究进展。
Biomed Res Int. 2019 Aug 14;2019:5763602. doi: 10.1155/2019/5763602. eCollection 2019.
4
CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.CYP3A4 诱导剂和抑制剂强烈影响雷公藤红素及其衍生物在大鼠体内的药代动力学。
Acta Pharmacol Sin. 2018 Aug;39(8):1386-1392. doi: 10.1038/aps.2017.170. Epub 2017 Dec 28.
5
Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1.薯蓣皂苷通过诱导自噬增强阿霉素在 MCF-7 和 MCF-7/ADR 细胞中的疗效:不仅仅是下调多药耐药蛋白 1。
Sci Rep. 2016 Jun 22;6:28403. doi: 10.1038/srep28403.